NOV.DE vs. SOF.BR
NOV.DE (Novo Nordisk A/S) and SOF.BR (Sofina Société Anonyme) are both stocks. NOV.DE operates in Biotechnology (Healthcare), while SOF.BR operates in Asset Management (Financial Services). Over the past 10 years, NOV.DE returned 17.16%/yr vs 8.03%/yr for SOF.BR. At a 0.15 correlation, their price movements are largely independent.
Performance
NOV.DE vs. SOF.BR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NOV.DE achieves a -10.35% return, which is significantly higher than SOF.BR's -11.22% return. Over the past 10 years, NOV.DE has outperformed SOF.BR with an annualized return of 17.16%, while SOF.BR has yielded a comparatively lower 8.03% annualized return.
NOV.DE
- 1D
- 0.21%
- 1M
- -0.63%
- YTD
- -10.35%
- 6M
- -8.05%
- 1Y
- -42.30%
- 3Y*
- 4.29%
- 5Y*
- 20.26%
- 10Y*
- 17.16%
SOF.BR
- 1D
- 2.26%
- 1M
- 0.78%
- YTD
- -11.22%
- 6M
- -7.94%
- 1Y
- -13.53%
- 3Y*
- 3.50%
- 5Y*
- -8.43%
- 10Y*
- 8.03%
NOV.DE vs. SOF.BR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOV.DE Novo Nordisk A/S | -10.35% | -45.88% | -9.45% | 201.62% | 32.53% | 76.94% | 16.00% | 38.98% | -7.34% | 39.52% |
SOF.BR Sofina Société Anonyme | -11.22% | 14.69% | -1.65% | 11.37% | -51.86% | 57.47% | 45.71% | 17.99% | 28.74% | 6.68% |
Correlation
The correlation between NOV.DE and SOF.BR is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Nov 28, 2006 | 0.15 |
The correlation between NOV.DE and SOF.BR shifts across timeframes, from 0.05 (3 years) to 0.15 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOV.DE vs. SOF.BR — Risk / Return Rank
NOV.DE
SOF.BR
NOV.DE vs. SOF.BR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOV.DE) and Sofina Société Anonyme (SOF.BR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOV.DE | SOF.BR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.16 | ||
| Sortino ratioReturn per unit of downside risk | -0.23 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 0.90 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | -0.61 | -0.19 |
| Martin ratioReturn relative to average drawdown | -1.16 | -1.08 | -0.07 |
Loading charts...
Drawdowns
NOV.DE vs. SOF.BR - Drawdown Comparison
The maximum NOV.DE drawdown since its inception was -76.24%, which is greater than SOF.BR's maximum drawdown of -59.53%. Use the drawdown chart below to compare losses from any high point for NOV.DE and SOF.BR.
Loading charts...
Drawdown Indicators
| NOV.DE | SOF.BR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.24% | -59.53% | -16.71% |
Max Drawdown (1Y)Largest decline over 1 year | -53.78% | -26.62% | -27.16% |
Max Drawdown (3Y)Largest decline over 3 years | -76.24% | -26.62% | -49.62% |
Max Drawdown (5Y)Largest decline over 5 years | -76.24% | -59.53% | -16.71% |
Max Drawdown (10Y)Largest decline over 10 years | -76.24% | -59.53% | -16.71% |
Current DrawdownCurrent decline from peak | -70.33% | -46.64% | -23.69% |
Average DrawdownAverage peak-to-trough decline | -11.57% | -19.13% | +7.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.53% | 15.02% | +20.51% |
Volatility
NOV.DE vs. SOF.BR - Volatility Comparison
Novo Nordisk A/S (NOV.DE) has a higher volatility of 9.39% compared to Sofina Société Anonyme (SOF.BR) at 6.23%. This indicates that NOV.DE's price experiences larger fluctuations and is considered to be riskier than SOF.BR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOV.DE | SOF.BR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.39% | 6.23% | +3.16% |
Volatility (6M)Calculated over the trailing 6-month period | 37.99% | 16.85% | +21.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.46% | 23.40% | +27.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.30% | 28.53% | +28.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.50% | 24.81% | +19.69% |
Dividends
NOV.DE vs. SOF.BR - Dividend Comparison
NOV.DE's dividend yield for the trailing twelve months is around 4.10%, more than SOF.BR's 1.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOV.DE Novo Nordisk A/S | 4.10% | 3.54% | 1.59% | 1.02% | 2.36% | 2.54% | 3.97% | 4.18% | 5.34% | 4.55% | 7.38% | 2.50% |
SOF.BR Sofina Société Anonyme | 1.18% | 1.41% | 1.53% | 1.44% | 1.52% | 0.70% | 1.05% | 1.45% | 1.61% | 1.95% | 1.96% | 2.21% |
Financials
NOV.DE vs. SOF.BR - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Sofina Société Anonyme. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NOV.DE and SOF.BR have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOV.DE and SOF.BR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer